Company Profile

Smart Quotes

MANKIND PHARMA LTD.

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private

BSE2368.00-13.95 (-0.59 %)

PREV CLOSE ( ) 2381.95

OPEN PRICE ( ) 2372.15

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 6420

TODAY'S LOW / HIGH ( )2336.55 2384.25

52 WK LOW / HIGH ( )1910.1 3050

NSE2370.00-11.3 (-0.47 %)

PREV CLOSE( ) 2381.30

OPEN PRICE ( ) 2380.00

BID PRICE (QTY) 2370.00 (126)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 251064

TODAY'S LOW / HIGH( ) 2336.40 2383.70

52 WK LOW / HIGH ( )1901.05 3054.8

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 03-07 1991

Management Info

Ramesh Juneja - Chairman Rajeev Juneja - Managing Director

Registered Office

Address 208,Okhla Industrial Estate,Phase - 111,
New Delhi,
Delhi-110020

Phone 011-46846700

Email contact@mankindpharma.com

Website www.mankindpharma.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

10Jun Mankind Pharma informs about allotment
Mankind Pharma has informed that the Nomination and Remuneration Committ..

05Jun Mankind Pharma gets ESG score of 38.98
ISS ESG has voluntarily issued an Environmental, Social and Governance (..

05Jun Mankind Pharma gains on the BSE
Mankind Pharma is currently trading at Rs. 2357.25, up by 10.55 points o..

22May Mankind Pharma gets nod to incorporate
Mankind Pharma has received approval for incorporation of wholly owned s..

22May Mankind Pharma reports 11% fall in Q4
Mankind Pharma has reported results for fourth quarter (Q4) and year end..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	3824.6	19454.8
Gross Profit	4287.5	23059.9
Operating Profit	6962.4	30557.6
Net Sales	21265.9	94978

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Onesource Specialty (BSE) 2164.40 (6.92%)	M.Cap ( in Cr)24775.03
Abbott India (BSE) 31658.15 (0.36%)	M.Cap ( in Cr)67271.36
Gland Pharma (BSE) 1769.05 (4.72%)	M.Cap ( in Cr)29146.24
Procter&Gamble Healt (BSE) 5907.60 (1.17%)	M.Cap ( in Cr)9806.25
Glaxosmithkline Phar (BSE) 3366.50 (2.04%)	M.Cap ( in Cr)57030.54

Shareholding Pattern

	PROMOTERS	72.7%
	MUTUAL FUNDS/UTI	7.67%
	NON-INSTITUTION	2.93%
	FI/BANKS/INSURANCE	2.23%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Tata Nifty MidSmall Healthcare Index Fund-Reg(G)	4.97
Motilal Oswal Nifty MidSmall Healthcare Index Fund-Reg(G)	4.96
PGIM India Healthcare Fund-Reg(G)	4.90
Invesco India Focused Fund-Reg(G)	3.88
SBI Healthcare Opp Fund-Reg(IDCW)	3.76
Nippon India Nifty Pharma ETF	3.64
Motilal Oswal Nifty MidSmall India Consumption Index Fund-Reg(G)	3.63